PMID 41500720
Yates T, Haffner SM, Schulte PJ et al (2014) Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis
Obesity, a pervasive global health challenge, transcends borders, impacting millions with profound consequences to their well-being and quality of life
Wegovy 0.5 mg, FlexTouch solution for injection in pre-filled pen Summary of Product Characteristics
For example, in Canada, attention is already shifting towards newer entrants like tirzepatide (Mounjaro/Zepbound), which has demonstrated superior efficacy in weight loss in the head-to-head SURMOUNT-5 trial iii and is gaining momentum
Most of the prescriptions so far have been for the lowest dose, also known as the starter dose, which is typically used by people just beginning weight loss treatment